With science-backed GLP-1 medications like Semaglutide and Tirzepatide, Willow offers doctor-supervised treatment that helps curb hunger and control cravings
These patients should discuss their gastrointestinal history with their prescriber before starting treatment
86 In patients with T2D and high cardiovascular risk, semaglutide use has resulted in fewer serious cardiac and kidney disorders compared to placebo but is linked to worsening diabetic retinopathy, likely due to rapid glucose reduction
Targeting antioxidants specifically to the mitochondria is of particular interest, given that more than 80% of reactive oxygen species (ROS) are generated at this site
Modifying dilution, speed, or anatomical location costs nothing but prevents reactions that derail weeks of treatment
All patients receive a custom diet and exercise plan included in their program